355 related articles for article (PubMed ID: 25843763)
1. Leukapheresis in acute myeloid leukemia patients with hyperleukocytosis: A single center experience.
Berber I; Kuku I; Erkurt MA; Kaya E; Bag HG; Nizam I; Koroglu M; Ozgul M; Bazna S
Transfus Apher Sci; 2015 Oct; 53(2):185-90. PubMed ID: 25843763
[TBL] [Abstract][Full Text] [Related]
2. Leukapheresis treatment in elderly acute leukemia patients with hyperleukocytosis: A single center experience.
Berber I; Erkurt MA; Kuku I; Kaya E; Gozukara Bag H; Nizam I; Koroglu M; Yigit A; Ozgul M
J Clin Apher; 2016 Feb; 31(1):53-8. PubMed ID: 26011305
[TBL] [Abstract][Full Text] [Related]
3. Leukapheresis do not improve early death rates in acute myeloid leukemia patients with hyperleukocytosis.
Malkan UY; Ozcebe OI
Transfus Apher Sci; 2017 Dec; 56(6):880-882. PubMed ID: 29153308
[TBL] [Abstract][Full Text] [Related]
4. Hyperleukocytosis and leukocytapheresis in acute leukaemias: experience from a single centre and review of the literature of leukocytapheresis in acute myeloid leukaemia.
Bruserud Ø; Liseth K; Stamnesfet S; Cacic DL; Melve G; Kristoffersen E; Hervig T; Reikvam H
Transfus Med; 2013 Dec; 23(6):397-406. PubMed ID: 23919332
[TBL] [Abstract][Full Text] [Related]
5. Leukapheresis in childhood acute leukemias: single-center experience.
Yilmaz D; Karapinar B; Karadaş N; Duyu M; Yazici P; Ay Y; Balkan C; Aydinok Y; Kavakli K
Pediatr Hematol Oncol; 2014 May; 31(4):318-26. PubMed ID: 23988130
[TBL] [Abstract][Full Text] [Related]
6. The effect of therapeutic leukapheresis on early complications and outcomes in patients with acute leukemia and hyperleukocytosis: a propensity score-matched study.
Choi MH; Choe YH; Park Y; Nah H; Kim S; Jeong SH; Kim HO
Transfusion; 2018 Jan; 58(1):208-216. PubMed ID: 28960357
[TBL] [Abstract][Full Text] [Related]
7. Leukapheresis and exchange transfusion in children with acute leukemia and hyperleukocytosis. A single center experience.
Haase R; Merkel N; Diwan O; Elsner K; Kramm CM
Klin Padiatr; 2009; 221(6):374-8. PubMed ID: 19890790
[TBL] [Abstract][Full Text] [Related]
8. Early Complications of Hyperleukocytosis and Leukapheresis in Childhood Acute Leukemias.
Abla O; Angelini P; Di Giuseppe G; Kanani MF; Lau W; Hitzler J; Sung L; Naqvi A
J Pediatr Hematol Oncol; 2016 Mar; 38(2):111-7. PubMed ID: 26794706
[TBL] [Abstract][Full Text] [Related]
9. Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis.
Bug G; Anargyrou K; Tonn T; Bialleck H; Seifried E; Hoelzer D; Ottmann OG
Transfusion; 2007 Oct; 47(10):1843-50. PubMed ID: 17880610
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic leukapheresis in hyperleukocytic leukaemias--the experience of a tertiary institution in Singapore.
Tan D; Hwang W; Goh YT
Ann Acad Med Singap; 2005 Apr; 34(3):229-34. PubMed ID: 15902342
[TBL] [Abstract][Full Text] [Related]
11. Leukapheresis reduces 4-week mortality in acute myeloid leukemia patients with hyperleukocytosis - a retrospective study from a tertiary center.
Nan X; Qin Q; Gentille C; Ensor J; Leveque C; Pingali SR; Phan AT; Rice L; Iyer S
Leuk Lymphoma; 2017 Sep; 58(9):1-11. PubMed ID: 28140714
[TBL] [Abstract][Full Text] [Related]
12. Minimally early morbidity in children with acute myeloid leukemia and hyperleukocytosis treated with prompt chemotherapy without leukapheresis.
Chen KH; Liu HC; Liang DC; Hou JY; Huang TH; Chang CY; Yeh TC
J Formos Med Assoc; 2014 Nov; 113(11):833-8. PubMed ID: 24534017
[TBL] [Abstract][Full Text] [Related]
13. The role of therapeutic leukapheresis in hyperleukocytotic AML.
Pastore F; Pastore A; Wittmann G; Hiddemann W; Spiekermann K
PLoS One; 2014; 9(4):e95062. PubMed ID: 24733550
[TBL] [Abstract][Full Text] [Related]
14. Leukocytapheresis for patients with acute myeloid leukemia presenting with hyperleukocytosis and leukostasis: a contemporary appraisal of outcomes and benefits.
Shallis RM; Stahl M; Bewersdorf JP; Hendrickson JE; Zeidan AM
Expert Rev Hematol; 2020 May; 13(5):489-499. PubMed ID: 32248712
[No Abstract] [Full Text] [Related]
15. Leukapheresis for the management of hyperleukocytosis in acute myeloid leukemia-A systematic review and meta-analysis.
Bewersdorf JP; Giri S; Tallman MS; Zeidan AM; Stahl M
Transfusion; 2020 Oct; 60(10):2360-2369. PubMed ID: 32776542
[TBL] [Abstract][Full Text] [Related]
16. Leukapheresis and low-dose chemotherapy do not reduce early mortality in acute myeloid leukemia hyperleukocytosis: a systematic review and meta-analysis.
Oberoi S; Lehrnbecher T; Phillips B; Hitzler J; Ethier MC; Beyene J; Sung L
Leuk Res; 2014 Apr; 38(4):460-8. PubMed ID: 24472688
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic leukocytapheresis in infants and children with leukemia and hyperleukocytosis: A single institution experience.
Thapa N; Pham R; Cole C; Meinershagen M; Bowman PW; Ray A
J Clin Apher; 2018 Jun; 33(3):316-323. PubMed ID: 29193219
[TBL] [Abstract][Full Text] [Related]
18. Comparing leukapheresis protocols for an AML patient with symptomatic leukostasis.
Cline A; Jajosky R; Shikle J; Bollag R
J Clin Apher; 2018 Jun; 33(3):396-400. PubMed ID: 28940295
[TBL] [Abstract][Full Text] [Related]
19. Comparison of early mortality between leukapheresis and non-leukapheresis in adult acute myeloid leukemia patients with hyperleukocytosis: a systematic review and meta-analysis.
Rinaldi I; Sutandyo N; Winston K
Hematology; 2022 Dec; 27(1):141-149. PubMed ID: 35068391
[TBL] [Abstract][Full Text] [Related]
20. Impact of pre-induction therapy leukapheresis on treatment outcome in adult acute myelogenous leukemia presenting with hyperleukocytosis.
Thiébaut A; Thomas X; Belhabri A; Anglaret B; Archimbaud E
Ann Hematol; 2000 Sep; 79(9):501-6. PubMed ID: 11043421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]